EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Chromophobe renal cell carcinoma with ipsilateral ureteral urothelial carcinoma: A case report

Peirui Wang, Ling Wang, Jiang Du, Guobiao Liang

Molecular and Clinical Oncology · 21.02.2023 · 18 (4)

DOI: 10.3892/mco.2023.2626 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Molecular and Clinical Oncology, online erschienen am 21.02.2023. Verfasst von Peirui Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563003, P.R. China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

chromophobe renal cell carcinomadiagnosismultiple primary cancers of the urinary tractprognosistreatmentureteral urothelial carcinoma

Autor:innen und Institutionen

  • Department of Urology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563003, P.R. China.
  • Department of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563003, P.R. China.

Zitieren

APA

Wang, P., Wang, L., Du, J., & Liang, G. (2023). Chromophobe renal cell carcinoma with ipsilateral ureteral urothelial carcinoma: A case report. Molecular and Clinical Oncology, 18(4). https://doi.org/10.3892/mco.2023.2626

Vancouver

Wang P, Wang L, Du J, Liang G. Chromophobe renal cell carcinoma with ipsilateral ureteral urothelial carcinoma: A case report. Molecular and Clinical Oncology. 2023;18(4). doi:10.3892/mco.2023.2626

BibTeX
@article{Wang2023,
  author = {Wang, Peirui and Wang, Ling and Du, Jiang and Liang, Guobiao},
  title = {Chromophobe renal cell carcinoma with ipsilateral ureteral urothelial carcinoma: A case report},
  journal = {Molecular and Clinical Oncology},
  year = {2023},
  volume = {18},
  number = {4},
  doi = {10.3892/mco.2023.2626}
}
Kostenlos starten →